Federal OSHA · osha.gov
Other Organics & Carcinogens

Formaldehyde Medical Surveillance

Formaldehyde causes nasopharyngeal cancer, respiratory/skin sensitization, and mucous-membrane irritation; affects workers in resin/plastics, textiles, embalming, and wood-products manufacturing.

Action Level0.5 ppm (8-hr TWA)
PEL0.75 ppm (8-hr TWA); STEL 2 ppm / 15 min
Who is covered: All employees exposed at/above the action level OR exceeding the STEL; employees who develop signs/symptoms of overexposure; and employees exposed in emergencies

Evaluation performed by: Licensed physician (employer-selected)

🩺 Baseline / Pre-Placement

Prior to job assignment for covered employees

  • Medical disease questionnaire (Appendix D) — standardized form covering work history, smoking history, eye/nose/throat irritation, chronic or hyperreactive airway disease, allergic skin conditions/dermatitis, and upper/lower respiratory problems [1910.1048(l)(3)(i)]
  • Physician-administered medical examination (only if the questionnaire or physician indicates the employee may be at increased risk, or for respirator wearers) emphasizing irritation/sensitization of skin and respiratory system, shortness of breath, and eye irritation [1910.1048(l)(4)(i)]
  • Baseline pulmonary function tests — FVC, FEV1, FEF — for employees required to wear respirators [1910.1048(l)(4)(ii)]
🕒 Periodic / Routine

Interval-based while covered — NOT result-triggered

Schedule: Medical disease questionnaire (Appendix D) administered at least annually for all covered employees. For employees required to wear respirators, a medical examination including annual pulmonary function tests (FVC, FEV1, FEF) at least annually. [1910.1048(l)(3), (l)(4)]

  • Annual medical disease questionnaire (Appendix D)
  • Physician physical examination (respirator wearers / flagged employees) emphasizing skin and respiratory irritation/sensitization, shortness of breath, eye irritation [1910.1048(l)(4)(i)]
  • Annual pulmonary function tests — FVC, FEV1, FEF — for respirator wearers [1910.1048(l)(4)(ii)]
  • Any other test the examining physician deems necessary [1910.1048(l)(4)(iii)]
⚠ Emergency / Post-Exposure

Emergency exposure (uncontrolled release)

  • Medical examination as soon as possible after the emergency exposure [1910.1048(l)(5)]
  • Physical examination emphasizing skin/respiratory irritation and sensitization and eye irritation
  • Tests the examining physician deems necessary
Abnormal results & exposure-event protocols

Abnormal Results & Exposure-Event Protocols

  • Questionnaire response or physician judgment indicates the employee may be at increased risk from formaldehyde exposure 1910.1048(l)(4): Provide a physician-administered medical examination (history, physical, and any tests the physician deems necessary). Tests: Physical examination emphasizing skin and respiratory irritation/sensitization, shortness of breath, eye irritation, Pulmonary function tests if indicated, Other tests the physician deems necessary, Counseling for employees with conditions aggravated by formaldehyde exposure [1910.1048(l)(4)(iv)]
  • Examining physician determines the employee has significant irritation of the eyes or upper-airway mucosa, respiratory sensitization, or dermal irritation/sensitization attributed to workplace formaldehyde 1910.1048(l)(8)(i): Employer may, at its option, allow a 2-week evaluation and remediation period [(l)(8)(ii)] before a formal medical-removal examination; earnings, seniority, and benefits are unchanged during that period. If the condition persists, remove or transfer the employee. Tests: Follow-up medical evaluation to determine whether the condition has resolved with reduced exposure
  • Medical removal required because the condition does not resolve 1910.1048(l)(8)(vi)-(vii): Transfer the employee to comparable work where exposure is at or below the action level, maintaining current earnings, seniority, and benefits until comparable work is available, the employee is found unable to return, the employee is found able to return to the original job, or 6 months elapse — whichever comes first. A follow-up examination is provided within 6 months after removal. Tests: Follow-up medical examination within 6 months after removal [1910.1048(l)(8)(vii)]

Reporting Requirements

Who performs the evaluationLicensed physician
Reported to employerWritten medical opinion stating whether the employee has any medical condition that would place them at increased risk of material impairment of health from formaldehyde exposure, and any recommended limitations on exposure or use of PPE/respirators [1910.1048(l)(7)(i)(A)-(B)]. The opinion must NOT disclose specific findings or diagnoses unrelated to occupational exposure to formaldehyde.
Reported to / for the employeePhysician must inform the employee of any medical condition that may be aggravated by formaldehyde exposure and of the need for further examination or treatment [1910.1048(l)(7)(i)(C)]. Employer furnishes a copy of the physician's written opinion to the affected employee.
Time limitsEmployer furnishes the copy of the written opinion to the affected employee within 15 days of its receipt [1910.1048(l)(7)(iii)].
Second-opinion / multi-physician reviewStandard does not establish a formal multiple-physician review mechanism; physician selection is by the employer.
RecordkeepingMedical records kept for the duration of employment plus 30 years [1910.1048(o)(5)(ii); 29 CFR 1910.1020].

Medical Removal Protection

Removal/transfer triggered by physician-attributed significant eye/upper-airway irritation, respiratory sensitization, or dermal irritation/sensitization; optional 2-week evaluation/remediation period; transfer to comparable work at exposure ≤ action level maintaining earnings/seniority/benefits until comparable work is available, the employee returns, or 6 months elapse.

How this compares to Cal/OSHA: Substantively aligned — identical limits (AL 0.5 ppm, PEL 0.75 ppm, STEL 2 ppm), identical questionnaire-based triage (Appendix D), identical PFT triggers for respirator wearers (FVC/FEV1/FEF), and equivalent removal/transfer protections. California uses lettered subsections [(l)(1)(A)] where federal uses roman numerals; the difference is cosmetic. (CA 15-day written-opinion furnishing time marked unverified — not separately confirmed in 5217 text.)

Occu-Med handles Formaldehyde surveillance end-to-end

Scheduling, exams, lab panels, physician review, removal/return determinations, and audit-ready recordkeeping — fully compliant with Federal OSHA requirements.